跳至主要内容
临床试验/ITMCTR2200005556
ITMCTR2200005556尚未招募4 期

The protective effect of Guanxinning on panvascular disease in patients with stable angina pectoris

Hangzhou Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
30 至 80(—)
性别
All

入选标准

  • At the same time, it meets the above-mentioned diagnostic criteria for stable coronary heart disease and TCM heart and blood stasis syndrome. Coronary angiography or treadmill exercise test confirms that they are between 30 and 80 years old to participate in this test voluntarily and sign an informed consent form.

排除标准

  • ?Patients with unstable angina; ?Combined with acute infection, uncontrolled grade ? hypertension (systolic blood pressure =180mmHg and/or diastolic blood pressure =110mmHg), severe cardiopulmonary insufficiency (heart function grade ?, ?, severe pulmonary insufficiency) , Severe arrhythmia, severe diseases (such as tumors, etc.) and mental illness that affect their survival; ?Recently (6 months) with severe bleeding disease, active bleeding or surgical history; ?Within the past 1 month Patients with acute cerebral infarction and other traumatic brain injuries; ?platelet count <50×10 9 /L, hematocrit 30%; ? abnormal liver and kidney function indexes (ALT and AST exceed the upper limit of the normal reference range by 2 times, Ccr is low Less than 30ml/(min*1.73m2)); ?Patients who are allergic to the test drug (including its ingredients); ?Patients with pregnancy plans or pregnant or lactating women; ?Patients who have participated in other clinical trials within the past 1 month ; ? Alcoholism or drug addicts.

研究者

发起方
Hangzhou Hospital of Traditional Chinese Medicine

相似试验

The protective effect of Guanxinning on panvascular... | 临床试验